Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Thrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL)

Interventions

DRUG

Semuloparin sodium

"Solution for injection in single dose vials (10 mg/mL and 20 mg/mL)~Subcutaneous injection"

Trial Locations (1)

Investigational Site Number 348001, Budapest